58 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 58 of 58 clinical reviews.
Complete clinical guide to pioglitazone dosing in adolescents aged 12 to 17, covering FDA-approved indications, off-label NAFLD/NASH use, safety monitoring, titration schedules, and guideline recommendations.
A clinical deep-dive into pioglitazone safety in adolescents aged 12 to 17, covering weight gain, bone health, bladder risk, NASH evidence, and FDA-labeled dosing guidance.
A guide to pioglitazone safety for adults aged 30-49, covering cardiovascular effects, bladder cancer risk, fluid retention, bone fracture data, and monitoring protocols backed by clinical trial evidence.
Evidence-based guide to pioglitazone (Actos) drug-drug interactions, covering CYP2C8 inhibitors, insulin co-administration, heart failure risk multipliers, and clinical management strategies.
What Actos (pioglitazone) costs in Delaware in 2026, including cash prices, Medicaid coverage, insurance options, discount programs, and compounded alternatives.
What is actually verifiable about pioglitazone pricing, Medicaid coverage, and insurance in Hawaii, plus a checklist for confirming current numbers before you fill a prescription.
What Actos (pioglitazone) costs in Illinois in 2026, including cash prices, Medicaid coverage, insurance tiers, discount programs, and compounded options at 503A pharmacies.
Current pioglitazone prices in Indiana for 2026, including cash-pay costs, Medicaid coverage details, insurance options, discount programs, and compounding pharmacy availability.
What pioglitazone costs in Iowa in 2026. Cash prices, Iowa Medicaid coverage status, insurance options, 503A compounding, telehealth access, and discount programs explained.
What is actually established about pioglitazone (Actos) cost, coverage, and off-label use for New Hampshire patients in 2026, and what still needs to be verified with your own pharmacy, insurer, or the state Medicaid program.
What pioglitazone costs in Oregon in 2026, including Medicaid coverage, insurance copays, generic pricing, discount programs, and compounded options at 503A pharmacies.
What determines the price of Actos (pioglitazone) in South Dakota, how Medicaid and commercial insurance typically treat it, and what to verify before assuming a cash price, coverage rule, or discount applies to you.
Current pioglitazone prices in Virginia for 2026, including cash-pay costs, Medicaid coverage, insurance options, discount programs, and compounded alternatives.
Compare pioglitazone (Actos) pricing against metformin, rosiglitazone, SGLT2 inhibitors, and GLP-1 receptor agonists. Includes mechanism of action, NASH data from PIVENS, and insurance guidance.
Complete guide to pioglitazone (Actos) dosing in young adults aged 18 to 29, covering starting doses, titration, NASH off-label use, fertility considerations, and monitoring protocols.
Evidence-based guide to pioglitazone use in patients with liver disease. Covers FDA labeling, ALT thresholds, PIVENS trial data in NASH, monitoring protocols, and dose adjustment considerations.
Evidence-based guide to pioglitazone dosing in patients with chronic kidney disease. No dose adjustment is required, but fluid retention risks demand careful monitoring.
Evidence-based guide to pioglitazone (Actos) interactions with foods, supplements, and herbal products. Includes CYP2C8 pathway details, grapefruit data, and clinical recommendations.
A guide to pioglitazone (Actos) for NAFLD and MASLD: trial evidence, off-label dosing patterns, side-effect monitoring, and how it compares to newer agents like resmetirom and semaglutide.
Evidence-based guide to pioglitazone safety in adults 65 and older, covering fracture risk, heart failure, edema, bladder cancer concerns, drug interactions, and deprescribing strategies.
A detailed look at pioglitazone's manufacturing timeline, generic market evolution, FDA shortage records, and current supply status for this thiazolidinedione used in type 2 diabetes and off-label NASH.
A physician-level deep dive into how pioglitazone works, from PPARγ receptor activation and adiponectin upregulation to insulin sensitization, hepatic fat reduction, and anti-inflammatory signaling.
What to do when you miss a dose of pioglitazone (Actos). Evidence-based guidance on timing, pharmacokinetics, and when to skip vs. take your missed dose.
Evidence-based monitoring guide for pioglitazone (Actos) in adults aged 30, 49. Covers liver function tests, weight tracking, cardiac screening, bone density, and NASH-specific follow-up with clinical timelines.
A guide to monitoring pioglitazone (Actos) in adults aged 50 to 64, covering liver enzymes, heart failure screening, bone density, bladder surveillance, and polypharmacy checks.
Evidence-based monitoring guide for young adults aged 18 to 29 taking pioglitazone (Actos) for type 2 diabetes or NASH. Covers liver function tests, weight tracking, bone density, fertility considerations, and lab schedules.
A guide to pioglitazone (Actos) monitoring: which labs to order, how often, what thresholds trigger action, and how the drug's PPAR-gamma mechanism shapes every safety check.
A clinical review of pioglitazone's off-label applications including NASH/MASLD, stroke prevention, PCOS, and lipodystrophy, with trial data, dosing, and evidence grades.
A review of pioglitazone's patent history, generic entry, mechanism of action, and current prescribing field, distinguishing FDA-approved use from off-label use and flagging claims that need primary-source verification.
A clinician-focused guide to pioglitazone (Actos) dosing in children under 12, covering FDA labeling, off-label use, NASH evidence from PIVENS, safety monitoring, and practical prescribing steps.
Pioglitazone (Actos) is not FDA-approved for children under 12. This evidence-based review covers pediatric safety data, off-label NASH considerations, weight gain risks, bone density concerns, and monitoring protocols for young patients.
How CYP2C8, PPARG, and other gene variants alter pioglitazone metabolism, efficacy, and side-effect risk. Evidence-based pharmacogenomic guidance for clinicians and patients.
A physician-level review of pioglitazone (Actos) pharmacokinetics covering oral absorption, protein binding, CYP-mediated metabolism, active metabolites M-III and M-IV, and renal/fecal elimination with PubMed-cited evidence.
Evidence-based review of pioglitazone (Actos) safety during pregnancy and breastfeeding, including FDA labeling, animal data, clinical alternatives, and lactation pharmacokinetics.
A physician-level review of pioglitazone (Actos) real-world evidence from registries, claims databases, and observational cohorts covering cardiovascular outcomes, NASH/MASLD resolution, and long-term safety.
A guide to pioglitazone's approval history, current regulatory standing, label restrictions, and off-label use in NASH across the United States, European Union, Canada, and the United Kingdom.
Evidence-based guide to pioglitazone (Actos) safety for adults aged 50 to 64, covering cardiovascular outcomes, fracture risk, bladder cancer concerns, NASH data, and monitoring protocols.
A clinical review of pioglitazone safety for young adults aged 18 to 29, covering weight gain, bone density, fertility effects, bladder cancer risk, and monitoring protocols.
A comprehensive guide to pioglitazone (Actos) safety signals, FDA warnings, black box updates, and the clinical evidence behind each regulatory action.
Evidence-based guide to pioglitazone (Actos) storage conditions, shelf life, stability data, and real-world handling. FDA label requirements, ICH testing results, and clinical pharmacist recommendations.
A guide to discontinuing pioglitazone safely, covering tapering protocols, rebound hyperglycemia risk, NASH off-label use, mechanism of action, and what lab work to monitor when stopping Actos.
Pioglitazone (Actos) is an oral tablet, not an injectable. Learn how this PPAR-gamma agonist works, what the PIVENS trial proved about NASH, standard dosing, and when clinicians consider it over other agents.
Evidence-based switching protocols for pioglitazone (Actos), including when to transition to or from other thiazolidinediones, metformin, sulfonylureas, SGLT2 inhibitors, and GLP-1 receptor agonists.
A clinical and coverage deep-dive on whether Anthem (Elevance Health) covers pioglitazone (Actos) for type 2 diabetes and off-label NASH, including PA criteria, step therapy, formulary tiers, appeals, and cost strategies.
Find out whether Cigna covers Actos (pioglitazone) for type 2 diabetes and off-label NASH, including formulary placement, prior authorization requirements, step therapy rules, and how to appeal a denial.
Find out whether Medicare Advantage plans cover Actos (pioglitazone) for type 2 diabetes and off-label NASH, including formulary tiers, prior authorization criteria, step therapy rules, and how to appeal a denial.
A state-by-state breakdown of Medicaid coverage for pioglitazone (Actos), including prior authorization criteria, formulary tiers, step-therapy requirements, appeal strategies, and cash-pay alternatives.
A complete guide to obtaining a pioglitazone (Actos) prescription in California, including telehealth options, pharmacy access, Medi-Cal coverage, prior authorization, and required lab work.
A complete guide to getting a pioglitazone (Actos) prescription in Delaware, including telehealth options, pharmacy access, prior authorization steps, and required labs.
A complete guide to obtaining a pioglitazone (Actos) prescription in Georgia, including telehealth options, pharmacy access, prior authorization steps, and Georgia Medicaid coverage details.
A guide to obtaining pioglitazone (Actos) in Hawaii: telehealth and in-person prescribing, required labs, pharmacy access across the islands, and where insurance coverage actually gets complicated.
A guide to obtaining pioglitazone (Actos) in Indiana, covering telehealth prescribing, pharmacy options, prior authorization, labs, and Medicaid coverage status.
A guide to obtaining pioglitazone in Louisiana, covering telehealth prescribing, pharmacy access, prior authorization, and Louisiana Medicaid coverage status.
Learn how to get an Actos (pioglitazone) prescription in Massachusetts through telehealth or in-person providers, including labs, prior authorization, pharmacy options, and Medicaid coverage.
A complete guide to obtaining a pioglitazone (Actos) prescription in New York, including telehealth options, pharmacy access, insurance coverage, prior authorization, and required labs.
A clinical guide to obtaining pioglitazone in Wisconsin, covering telehealth prescribing, pharmacy options, prior authorization, labs, and Wisconsin Medicaid coverage for type 2 diabetes and off-label NASH.
Pioglitazone starts at 15 to 30 mg once daily, titrated every 8 to 12 weeks up to a max of 45 mg based on A1C response and fluid-retention risk.
A clinical review of pioglitazone's evolving pipeline, including MASLD-targeted formulations, combination therapies, novel PPARγ agonists, and repurposing studies in neurodegeneration and cardiovascular prevention.